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ABSTRACT 
Hypertension is the most noteworthy risk factor for cardiovascular 
diseases and stroke. Dietary and lifestyle changes play the foremost part 
to decrease the hazard of hypertension and other related wellbeing 
complications. Angiotensin Converting Enzyme (ACE) inhibitors play a 
major role in treating hypertension. Annapavala chendhuram is a herbo – 
mineral Siddha formulation comes under the type of 32 internal 
medicines of Siddha. Hypolipidemic activity of Annapavala chendhuram 
has been proven by some research studies. Hence, the purpose of the 
present study was to evaluate the ACE inhibition activity on Annapavala 
chendhuram by using an in-vitro assay. The ACE inhibition assay was 
evaluated by UV Spectrophotometry technique based on the hydrolysis of 
histidyl-hippuryl-leucine (HHL) by ACE. About 50µL test sample with 
varying concentration (100- 500 µg/ml) along with standard captopril 
(100µg/ml) added with 50µL of ACE and some process had continued. 
The present study indicates that the test drug Annapavala chendhuram 
was effective in inhibiting the enzyme ACE dose-dependently. Maximum 
percentage inhibition of about 53.24±8.403% was observed at 500μg/ml 
when compared to that of the Captopril, a standard ACE enzyme inhibitor 
agent with the maximum inhibition 86.98 ± 6.375 at the concentration of 
100μg/ml. It was concluded that the test drug Annapavala chendhuram 
possess significant anti-hypertensive property in protein denaturation 
assay. So, further in-vitro evaluation of ACE inhibitory activity on Siddha 
herbal preparations and clinical trials will be the need of the hour.  
 
INTRODUCTION 
One of the largest single risk factors of 
deaths worldwide is hypertension. Cardiovascular 
disease and stroke are the world’s biggest killers, 
attributing for a combined 15.2 million deaths in 
2016. Globally these diseases have remained the 
leading causes of death within the last 15 years. 
Hypertension is that the most noteworthy risk 
factor for cardiovascular diseases and stroke.[1] 
Dietary and lifestyle changes play the foremost part 
to decrease the hazard of hypertension and other 
related wellbeing complications. However, 
therapeutic treatment may prove essential for 
patients whose lifestyle changes prove ineffective 
and inadequate.[2] Hypertension treatments have 
widely evolved from low sodium dietary regimens 
to an unlimited arsenal of contemporary 
pharmaceuticals. There are many choices for the 
treatment of hypertension. Some treatments 
include diuretics, β-blockers, calcium channel 
blockers and hypertension receptor blockers, the 
most common of which are angiotensin-converting 
enzyme inhibitors.[3] 
The Angiotensin-Converting Enzyme (ACE), 
the component of the renin-angiotensin-
aldosterone system (RAAS) plays a major role in 
regulating the blood pressure. Regulation of blood 
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pressure level by RAAS is via renin, angiotensin and 
aldosterone release.[4] Renin is released from 
juxtaglomerular apparatus of the kidney which 
splits angiotensinogen into angiotensin I. ACE is 
important for converting angiotensin I to 
angiotensin II, a known potent vasoconstrictor. 
Angiotensin II stimulates both the synthesis and 
release of aldosterone from the adrenal cortex 
leading torise in blood pressure level via sodium 
retention.[5] Thus, the concept of inhibiting ACE 
became a preferred and effective therapeutic 
approach in treating hypertension and other 
cardiovascular diseases. There are a plenty of 
synthetic ACE inhibitors available in the 
contemporary pharmaceuticals market like 
captopril and enalapril, have been used extensively 
as antihypertensive drugs. However, synthetic ACE 
inhibitors cause various adverse effects like cough, 
skin problems, nausea, Hyperkalemia, fatigue, 
dizziness, hypotension, renal impairment etc. so 
cheaper, safer alternatives are desirable.[6]  
Siddha system is that the ancient system of 
medicine mainly practiced within the southern part 
of India. It is one among the earliest traditional 
medicine systems within the world which treats not 
only the body but also the mind and also the soul.[7] 
Some of the drugs in traditional medicine were used 
for a long time ago to decrease the blood pressure 
level. But the scientific data on anti-hypertensive 
therapeutics is limited. Annapavala chendhuram is a 
Siddha herbo–mineral formulation comes under the 
type of 32 internal medicines of Siddha. Hypo-
lipidemic activity of Annapavala chendhuram has 
proven by some research. Hence, the aim of the 
present study was to explore the potential of ACE 
inhibition activity on Annapavala chendhuram by 
using an in-vitro assay. 
MATERIALS AND METHODS 
Ingredients of Annapavala Chendhuram [8] 
S. No Tamil Name Botanical/Chemical name Quantity 
1. Annabedhi Ferrous sulphate 227 gm 
2. Kodipavalam Corallium rubrum 170 gm 
3. Elumichai Citrus limon Required amount 
Procurement of the raw drug 
 The raw drug Annabedhi and Kodipavalam were procured from the authenticated raw drug shop at Chennai. 
Lemon was procured from the vegetable market, Tambaram, Chennai. 
Authentication of raw drugs 
Department of Geology, University of Madras, Chennai, authenticate the Kodipavalam and Annabedhi 
samples by analyzing the microscopical characters and literature sources. 
The purification process of raw drugs  
 Annabedhi:[9] 
Annabedhi was soaked in Lemon juice for 3 days and made it dry under the dark in an earthen vessel. 
 Kodipavalam:[9] 
Kodipavalam was soaked in the lemon juice for 3 days in an earthen vessel. It was kept under the 
sunlight for 3 days. Then 4th day Kodipavalam was washed with the water and wiped with a cloth. 
 Purification of raw drugs 
  
 
 
 
 
 
 
 
 
  
 
Fig 1: Before purification – Annabedhi  Fig 2: After purification - Annabedhi 
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Fig 3: Before purification – Kodipavalam  Fig 4: After purification - Kodipavalam 
Preparation method of Annapavala chendhuram [8] 
The trial drug Annapavala chendhuram was prepared in the Gunapadam Laboratory, National 
Institute of Siddha, Chennai. The purified Kodipavalam and Annabedhi were made into a fine powder 
separately and both powders were placed in Kalvam (mortar). It was ground well with lemon juice for six 
hours. Then it was made into Villai (pellets) and dried in sunlight. The pellets were put into an earthen 
vessel which was closed with another vessel and 7 clay cloth made to the margin of earthen vessels and the 
set up was dried in sunlight for one day. After that, it was put in a deep pit and Pudam process (incineration 
process) was done with 300 cow dung cakes. Once it cools the Pudam was opened and the pellets were 
taken out. The pellets were collected after cooling, weighed, finely powdered and stored in a clean, dry, 
airtight glass container. 
Dose: 120 – 260 mg. 
Adjuvant: Honey, Ghee, butter or Impurallegiyam. 
Indication: Kasam, Swasakasam, Shayam, Rakthaushnam, Pithaushnam, Mega ushnam and Aththijuram. This 
Chenduram may be given for all diseases with suitable Anubanam as an alternative medicine. 
Preparation method of Annapavala chenduram 
 
 
  
 
 
 
 
 
 
 
 
Fig 5: Fine powder of Annabedhi   Fig 6: Fine powder of Kodipavalam 
 
  
 
 
 
 
 
 
 
 
 
Fig 7: Grinding of Annabedhi                          Fig 8: Villai in clay sealed earthen vessel 
    Kodipavalam with lemon juice 
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Fig 9: Incineration with 300 cow dung cakes  Fig 10: Final grinding of APC 
Angiotensin Converting Enzyme (ACE) inhibition assay [10] 
ACE inhibition assay of the sample Annapavala chendhuram was performed based on the well-
established protocol using UV- Spectrophotometry technique based on the hydrolysis of histidyl-hippuryl-
leucine (HHL) by ACE. About 50µL test sample with varying concentration (100- 500 µg/ml) along with 
standard captopril (100 µg/ml) added with 50µL of ACE followed by incubation under 37°C for a brief time. 
Next phase of the reaction was initiated by addition of 150µL of the substrate (8.3 mM of HHL) with 
incubation at 37°C for 10 min time. Followed by this about 50µL of 1 M HCl was added to the reaction 
mixture to halt the reaction process. Hippuric acid thus formed will be eliminated by extraction with 1.5 mL 
ethyl acetate to the study mixture. Excess ethyl acetate was removed by heat evaporation. The final 
extracted product was dissolved in 3mL volume of DD water and the absorbance was determined at 228 nm 
using a spectrophotometer. The percentage inhibition activity was calculated using the following equation. 
The experiment was performed in triplicate. 
 
Statistical analysis 
Results are expressed as Mean ± SD. The difference between experimental groups was compared by 
One-Way Analysis of Variance (ANOVA) followed by Dunnett’s multiple comparison test. 
RESULTS 
The result obtained from the present study indicates that the test drug, Annapavala chendhuram was 
effective in inhibiting the enzyme ACE dose-dependently. Maximum percentage inhibition of about 
53.24±8.403% was observed at 500μg/ml when compared to that of the Captopril, a standard ACE enzyme 
inhibitor agent with the maximum inhibition 86.98 ± 6.375 at the concentration of 100μg/ml.  
Table 1: Percentage Inhibition of ACE at various concentration 
 Concentration in µg/ml Percentage Inhibition of ACE 
ANC 100 5. 80 ± 2.444 
ANC 200 20. 4 ± 9.953 
ANC 300 28. 65 ± 8.809 
ANC 400 42. 51 ± 1.435 
ANC 500 53. 24 ± 8.403 
Captopril (100 µg) 86.98 ± 6.375 
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Graph 1: Percentage Inhibition of ACE at various concentration 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANC – Annapavala chendhuram 
DISCUSSION
Hypertension, a worldwide illness, is a 
major factor in cardiovascular diseases that affects 
a large population of adults. Risk factors of 
hypertension are high salt and spicy food intake, 
alcohol consumption and tobacco use, low Calcium 
and Potassium intake, psychological stress, 
heredity, intake of fatty food which causes obesity 
and hyperlipidemia leading to atherosclerosis in 
blood vessels and physical inactivity. As per Siddha, 
Pithadosha is predominant in elevating the 
hypertension. In contemporary medicine, one of the 
most effective medications for the treatment of 
hypertension is Angiotensin-Converting Enzyme 
(ACE) inhibitors. Meanwhile, traditional medicines 
have been used for treating illnesses. Therefore, 
they can be important resources to develop new 
drug candidates.[11] Some studies revealed that the 
test drug Annapavala chendhuram possess 
hypolipidemic activity.[12] Hence, ACE inhibition 
evaluation was done on Annapavala chendhuram. 
This study indicated 53.24% at 500µg/ml. It may 
suggest for the prehypertensive stage. The standard 
drug captopril was used as a positive control. The 
first oral ACE inhibitor, captopril was considered a 
breakthrough in managing blood pressure and was 
also an early example of structure-based drug 
design.[13] Other synthetic ACE inhibitors which are 
widely used for clinical use in the treatment of 
hypertension include enalapril, alacepril, and 
lisinopril.[14] Due to the side effects of synthetic ACE 
inhibitors, traditional Siddha drug Annapavala 
chendhuram is the safe and affordable for 
management of hypertension. 
CONCLUSION 
Natural products of animals and plants 
origin have been used by humans since ancient 
times either in the pure forms or crude extracts to 
treat many diseases. Today mankind is looking 
towards the traditional medicines due to low side 
effects. This study concluded that the test drug 
Annapavala chenduram possess significant anti-
hypertensive property in protein denaturation 
assay. Many studies revealed that herbals possess 
the activity of ACE inhibition. So, further in-vitro 
evaluation of ACE inhibitor activity on Siddha 
herbal preparations and clinical trials will be the 
need of the hour.  
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